Search results
Results from the WOW.Com Content Network
The IRA's new, purported negotiations make a mockery of the voluntary and competitive private-sector negotiations that for years have lowered drug costs to below their list prices. These private ...
Donald Trump's Agenda 47 and the Heritage Foundation's Project 2025 provide plenty of clues into what health-care changes may be coming. How Trump’s Agenda 47, plus Project 2025, offer clues ...
A healthcare group purchasing organization (GPO) assists in promoting quality healthcare relief and assists diverse providers in effectively managing expenses. A GPO aggregates the purchasing volume of its members for various goods and services and develops contracts with suppliers through which members may buy at group price and terms if they ...
One major reason for high prescription drug prices in the United States relative to other countries is the inability of government-granted monopolies in the American health care sector to use their bargaining power to negotiate lower prices, and the American payer ends up subsidizing the world's R&D spending on drugs. [3] [4] [5]
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law requiring pharmaceutical companies to negotiate drug prices with the ...
Strategic Negotiations: A Theory of Change in Labor-Management Relations, a 1994 Harvard Business School Press publication, is a book on negotiation by the authors; Richard E. Walton, Joel Cutcher-Gershenfeld, and Robert McKersie. [1] The book explains concepts and strategies of negotiation to the reader.
Since September we have been in contract negotiations with the local Medi-Cal payer, Central California Alliance for Health; to date, we have been unable to negotiate an agreeable equitable contract.
The Mutual Gains Approach (MGA) to negotiation is a process model, based on experimental findings and hundreds of real-world cases, [1] [2] [3] [4] [5] [6] that lays ...